Currently Empty: ₹0.00
Hook
Can a foreign brand that never sold a single product in India still stop an Indian company from using its name? The answer changed trademark law forever.
Meet the Parties
- Whirlpool Corporation — A US home-appliance giant, famous worldwide but not selling in India, and without a registered trademark here.
- N.R. Dongre & Others — An Indian manufacturer selling washing machines under the brand name ‘Whirlpool’.
What Happened? (Facts)
Whirlpool had advertised its washing machines in international magazines circulating in India and had a trademark registration here that had lapsed.
N.R. Dongre started manufacturing and selling washing machines in India under the identical name ‘Whirlpool’, arguing that since Whirlpool neither sold in India nor held a valid registration, it had no enforceable right here.
Whirlpool sued for passing off, claiming its global reputation had already reached Indian consumers through advertisements and spillover publicity.
The Big Legal Question
- Can an unregistered, non-selling foreign trademark still be protected in India on the strength of its international reputation?
- Does ‘use’ of a trademark require actual sale, or can advertising and reputation alone establish rights?
What Did the Court Decide?
The Supreme Court ruled in favour of Whirlpool.
It held that trans-border reputation is enough to sustain a passing-off action, even without registration or actual sale in India.
Why Did the Court Think So? (Reasoning)
The Court reasoned that in a globalised, media-connected world, a brand’s reputation travels faster than its products. Indian consumers exposed to international publications already associated ‘Whirlpool’ with quality appliances, so allowing a local company to trade on that name would deceive the public and unfairly ride on goodwill it did not build.
The Golden Rule (Ratio Decidendi)
A trademark’s reputation can cross national borders through advertising and publicity; actual sale or registration in India is not mandatory to claim protection through a passing-off action.
The Golden Rule (Ratio Decidendi)
This is the foundation of the trans-border reputation doctrine, cited whenever an international brand fights local imitation in India — from luxury fashion houses to global tech names.
It shaped how Indian courts treat global goodwill in the age of the internet and social media, where reputation spreads instantly across borders.
Case Timeline
- 1980s–1990s — Whirlpool advertises internationally; trademark registration in India lapses.
- N.R. Dongre begins using ‘Whirlpool’ mark on washing machines sold in India.
- Whirlpool files passing-off suit in Delhi High Court; matter reaches Supreme Court.
- 1996 — Supreme Court rules in favour of Whirlpool, cementing trans-border reputation doctrine.
Compare It With Another Landmark Case
Toyota Jidosha v. Prius Auto Industries (2018) — The Supreme Court later clarified this doctrine isn’t unlimited: Toyota’s global ‘Prius’ fame wasn’t enough because it lacked proof of actual reputation among Indian consumers before the local company’s use began.
Relevant Articles/Sections
Trade and Merchandise Marks Act, 1958 (predecessor to Trade Marks Act, 1999); common law tort of passing off.
Exam Memory Hack
Whirlpool = ‘World-pool’ — reputation can pool in from anywhere in the world, even without a single sale at home.
Possible Exam Questions
- Short: What is trans-border reputation in trademark law?
- Long: Discuss the significance of N.R. Dongre v. Whirlpool Corporation in shaping Indian trademark jurisprudence.
- Problem-based: A foreign company never sells in India but is famous through global advertising. Can it stop an Indian company from using its name? Discuss with reference to relevant case law.
Key Legal Terms
Passing Off • Trans-Border Reputation • Unregistered Trademark • Goodwill • Deceptive Use
TARAJU Takeaway
Reputation is a form of property — even without a shop in India, a brand’s goodwill deserves protection if consumers here already know and trust the name.
1. Cadila Health Care Ltd. v. Cadila Pharmaceuticals Ltd. (2001) (2001) 5 SCC 73, Supreme Court of India
Hook
Two medicines. Similar names. One wrong dose. When lives are at stake, how similar is ‘too similar’ for a trademark?
Meet the Parties
- Cadila Health Care Ltd. — pharmaceutical company selling a drug under the name ‘Falcigo‘.
- Cadila Pharmaceuticals Ltd. — a company that had earlier been part of the same group, selling a drug under the name ‘Falcitab‘.
What Happened? (Facts)
Both companies, once part of the same corporate group before a split, sold anti-malarial drugs with names starting with ‘Falci’ (referencing Falciparum malaria).
Cadila Health Care sued Cadila Pharmaceuticals, alleging that ‘Falcitab’ was deceptively similar to its own ‘Falcigo’ and could confuse doctors, chemists, and patients.
The trial court and High Court found no strong likelihood of confusion; the matter reached the Supreme Court.
The Big Legal Question
- What test should courts apply to decide deceptive similarity between two pharmaceutical trademarks?
- Should pharmaceutical trademarks be held to a stricter standard than ordinary consumer goods, given the risk of medical error?
What Did the Court Decide?
The Supreme Court held that in the case of medicinal products, a stricter standard must be applied to prevent confusion, since even a small mix-up could be dangerous to public health.
It laid down a comprehensive multi-factor test for judging deceptive similarity between trademarks.
Why Did the Court Think So? (Reasoning)
The Court explained that ordinary consumers of medicines are not always highly educated or careful, and pharmacists working under pressure could make genuine errors between similarly named drugs.
Since a wrong medicine could cause serious harm, courts must weigh the nature of goods, class of purchasers, and mode of purchase far more cautiously than with everyday products like biscuits or clothes.
The Golden Rule (Ratio Decidendi)
For determining deceptive similarity, courts must consider the nature of the marks, the goods, the class of purchasers, the mode of purchase, and surrounding circumstances — with a stricter standard applied to medicinal and pharmaceutical products because public health is at stake.
Why This Case Matters Today
The Cadila test remains the go-to framework cited in virtually every Indian trademark infringement case involving deceptive similarity, not just pharma.
It continues to guide courts in balancing brand protection with consumer and public-safety concerns.
Case Timeline
- Cadila Group splits; both companies continue using ‘Falci-‘ prefixed drug names.
- Cadila Health Care sues for injunction; trial court and High Court deny relief.
- 2001 — Supreme Court lays down the multi-factor deceptive similarity test for pharmaceutical trademarks.
Compare It With Another Landmark Case
Parle Products v. J.P. & Co. (1960) — an earlier case establishing the basic ‘deceptive similarity’ doctrine for ordinary consumer goods like biscuits, which Cadila later refined and made stricter for medicines.
Relevant Articles/Sections
Trade and Merchandise Marks Act, 1958; principles now applied under Sections 9, 11 and 29 of the Trade Marks Act, 1999.
Exam Memory Hack
Think ‘Cadila = Careful’ — extra care, extra caution, because medicines can’t afford mix-ups.
Possible Exam Questions
- Short: What is the Cadila test for deceptive similarity?
- Long: Explain how the Supreme Court’s approach to trademark similarity differs for pharmaceutical products, with reference to Cadila Health Care v. Cadila Pharmaceuticals.
- Problem-based: Two drug companies market medicines with phonetically similar names. Analyse the likely outcome using the Cadila test.
Key Legal Terms
Deceptive Similarity • Multi-Factor Test • Pharmaceutical Trademarks • Public Interest • Passing Off
TARAJU Takeaway
When health is on the line, ‘almost the same name’ isn’t good enough — courts demand a much higher bar of distinctiveness for medicines.
1. Amritdhara Pharmacy v. Satya Deo Gupta (1963) AIR 1963 SC 449, Supreme Court of India
Hook
‘Amritdhara’ and ‘Lakshmandhara’ — two Ayurvedic tonics with different first names but a shared ending. Is that enough to confuse a village buyer? The Supreme Court said yes.
Meet the Parties
- Amritdhara Pharmacy — manufacturer of the well-known Ayurvedic medicine ‘Amritdhara’.
- Satya Deo Gupta — proprietor selling a similar Ayurvedic tonic under the name ‘Lakshmandhara’.
What Happened? (Facts)
Amritdhara had been selling its medicinal preparation for years under the registered name ‘Amritdhara’.
Satya Deo Gupta began marketing a similar medicine as ‘Lakshmandhara’, prompting Amritdhara to allege infringement and deceptive similarity.
The core dispute turned on the shared suffix ‘dhara’ and whether an average buyer — often rural, semi-literate — would be confused by phonetic and structural resemblance.
The Big Legal Question
- Should trademarks be compared by dissecting them into parts, or by looking at the overall impression they create?
- What standard of care should be attributed to the ‘average purchaser’ when judging likelihood of confusion?
What Did the Court Decide?
The Supreme Court held that the two names were deceptively similar, but — because the respondent had honestly and continuously used ‘Lakshmandhara’ since 1923 without objection (acquiescence) — it upheld the Registrar’s order allowing ‘Lakshmandhara’ to be registered on a restricted basis, for sale within the State of Uttar Pradesh only, rather than an outright win for Amritdhara across India.
It emphasised that marks must be judged as a whole, not by breaking them into syllables, and from the perspective of a person of average intelligence and imperfect recollection.
Why Did the Court Think So? (Reasoning)
The Court reasoned that ordinary buyers do not carry a photographic memory of trademarks — they recall a general impression, especially the sound of a name.
Since both words shared structure and phonetic rhythm, and were used for the same category of medicinal products aimed at similar buyers, confusion was likely even though the first parts of the words differed.
The Golden Rule (Ratio Decidendi)
Trademarks must be compared as a whole (the anti-dissection rule) and evaluated through the eyes of a person with average intelligence and imperfect recollection, not through a microscopic, side-by-side analysis.
Why This Case Matters Today
This case is the origin of the ‘overall impression’ and ‘imperfect recollection’ standards still applied today, including in recent cases like the Blenders Pride vs London Pride dispute.
It remains foundational to how Indian courts assess phonetic and structural similarity across all categories of goods.
Case Timeline
- Amritdhara sells its Ayurvedic tonic under a registered mark.
- Satya Deo Gupta begins selling ‘Lakshmandhara’ for a similar product.
- Dispute reaches the Supreme Court on appeal.
- 1963 — Supreme Court finds deceptive similarity but upholds registration of ‘Lakshmandhara’ restricted to Uttar Pradesh on grounds of acquiescence.
Compare It With Another Landmark Case
Pernod Ricard India v. Karanveer Singh Chhabra (2025) — a modern application of the same anti-dissection principle, where the Supreme Court held ‘Blenders Pride’ and ‘London Pride’ were not deceptively similar because the shared word ‘Pride’ was common and non-distinctive.
Relevant Articles/Sections
Trade Marks Act, 1940 (then in force); principles now read into Sections 9, 11 and 29 of the Trade Marks Act, 1999.
Exam Memory Hack
Don’t dissect — just glance. A confused buyer sees the whole word, not its syllables.
Possible Exam Questions
- Short: What is the anti-dissection rule in trademark law?
- Long: Discuss the test of ‘imperfect recollection’ laid down in Amritdhara Pharmacy v. Satya Deo Gupta and its continuing relevance.
- Problem-based: Two product names share a common suffix but differ in their first syllables. Will this amount to deceptive similarity? Discuss.
Key Legal Terms
Anti-Dissection Rule • Imperfect Recollection • Overall Impression • Phonetic Similarity • Average Purchaser
TARAJU Takeaway
Judge a trademark the way a real customer does — as a whole word remembered vaguely, not as letters lined up for comparison.

